Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.


Google Scholar 

Early Breast Cancer Trialists’ Collaborative G, Darby S, McGale P, Correa C, Taylor C, Arriagada R, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.

United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). UNSCEAR 2020/2021 Report. Annex A: Evaluation of Medical Exposure to Ionizing Radiation. New York, NY: United Nations; 2022.

Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137:e30–66.


Google Scholar 

Nardin S, Mora E, Varughese FM, D’Avanzo F, Vachanaram AR, Rossi V, et al. Breast cancer survivorship, quality of life, and late toxicities. Front Oncol. 2020;10:864.


Google Scholar 

Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys. 1995;31:1205–11.


Google Scholar 

Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol. 2003;45:55–75.


Google Scholar 

Jahng JWS, Little MP, No HJ, Loo BW Jr, Wu JC. Consequences of ionizing radiation exposure to the cardiovascular system. Nat Rev Cardiol. 2024;21:880–98.


Google Scholar 

Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133:1104–14.


Google Scholar 

Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Moller H. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer. 2007;7:9.


Google Scholar 

McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson NO, Bennet AM, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol. 2011;100:167–75.


Google Scholar 

Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98.


Google Scholar 

Doyle JJ, Neugut AI, Jacobson JS, Wang J, McBride R, Grann A, et al. Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. Int J Radiat Oncol Biol Phys. 2007;68:82–93.


Google Scholar 

Boekel NB, Schaapveld M, Gietema JA, Rutgers EJ, Versteegh MI, Visser O, et al. Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2014. https://doi.org/10.1093/jnci/dju156.


Google Scholar 

Bouillon K, Haddy N, Delaloge S, Garbay JR, Garsi JP, Brindel P, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011;57:445–52.


Google Scholar 

Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6:557–65.


Google Scholar 

Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108:179–82.


Google Scholar 

Jingu K, Umezawa R, Yamamoto T, Takahashi N, Suzuki YU, Kishida K, et al. Recent postoperative radiotherapy for left-sided breast cancer does not increase mortality of heart disease in Asians or Pacific Islanders: SEER database analysis. Anticancer Res. 2023;43:3571–7.


Google Scholar 

Carlson LE, Watt GP, Tonorezos ES, Chow EJ, Yu AF, Woods M, et al. Coronary artery disease in young women after radiation therapy for breast cancer: the WECARE study. JACC CardioOncol. 2021;3:381–92.


Google Scholar 

Chang JS, Shin J, Park EC, Kim YB. Risk of cardiac disease after adjuvant radiation therapy among breast cancer survivors. Breast. 2019;43:48–54.


Google Scholar 

Chung SY, Oh J, Chang JS, Shin J, Kim KH, Chun KH, et al. Risk of cardiac disease in patients with breast cancer: impact of patient-specific factors and individual heart dose from three-dimensional radiation therapy planning. Int J Radiat Oncol Biol Phys. 2021;110:473–81.


Google Scholar 

Rehammar JC, Jensen MB, McGale P, Lorenzen EL, Taylor C, Darby SC, et al. Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977–2005. Radiother Oncol. 2017;123:299–305.


Google Scholar 

Boekel NB, Duane FK, Jacobse JN, Hauptmann M, Schaapveld M, Sonke GS, et al. Heart failure after treatment for breast cancer. Eur J Heart Fail. 2020;22:366–74.


Google Scholar 

Kim DY, Youn JC, Park MS, Lee S, Choi SW, Ryu KH, et al. Cardiovascular outcome of breast cancer patients with concomitant radiotherapy and chemotherapy: a 10-year multicenter cohort study. J Cardiol. 2019;74:175–81.


Google Scholar 

Vo JB, Ramin C, Veiga LHS, Brandt C, Curtis RE, Bodelon C, et al. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors. J Natl Cancer Inst. 2024;116:1384–94.


Google Scholar 

Choi DW, Guk MY, Kim HR, Ryu KS, Kong HJ, Cha HS, et al. Data resource profile: the Cancer public library database in South Korea. Cancer Res Treat. 2024;56:1014–26.


Google Scholar 

Ministry of Health and Welfare; National Cancer Data Center; Korea Health Information Service. Cancer Public Sample Database Documentation. Version 1.0. Gyeonggi-do, South Korea: National Cancer Data Center; 2024. (in Korean)

Health Insurance Review & Assessment Service. Details on the criteria and methods for applying health insurance benefits for medications prescribed to cancer patients. Gangwon-do, South Korea: health insurance review & assessment service; 2024. (in Korean)

National Cancer Institute Surveillance, epidemiology, and end results program. SEER*Rx—interactive antineoplastic drugs database. Accessed July 31, 2025. https://seer.cancer.gov/tools/seerrx/

Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51:524–32.


Google Scholar 

Koric A, Chang CP, Mark B, Rowe K, Snyder J, Dodson M, et al. Cardiovascular disease risk in long-term breast cancer survivors: a population-based cohort study. Cancer. 2022;128:2826–35.


Google Scholar 

Dai H, Bragazzi NL, Younis A, Zhong W, Liu X, Wu J, et al. Worldwide trends in prevalence, mortality, and disability-adjusted life years for hypertensive heart disease from 1990 to 2017. Hypertension. 2021;77:1223–33.


Google Scholar 

Shin DW, Cho J, Park JH, Cho B. National general health screening program in Korea: history, current status, and future direction. Precis Future Med. 2022;6:9–31.


Google Scholar 

Seo SR, Jang SY, Cho SI. Trends in incidence and case fatality rates of heart disease and its subtypes in Korea, 2006-2015. Int J Environ Res Public Health. 2020. https://doi.org/10.3390/ijerph17228451.


Google Scholar 

Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, et al. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2016;34:1122–30.


Google Scholar 

Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99:365–75.


Google Scholar 

Strongman H, Gadd S, Matthews A, Mansfield KE, Stanway S, Lyon AR, et al. Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet. 2019;394:1041–54.


Google Scholar 

Valiyaveettil D, Joseph D, Malik M. Cardiotoxicity in breast cancer treatment: causes and mitigation. Cancer Treat Res Commun. 2023;37:100760.


Google Scholar 

Henson KE, McGale P, Darby SC, Parkin M, Wang Y, Taylor CW. Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: cohort study of 2 million women from 57 cancer registries in 22 countries. Int J Cancer. 2020;147:1437–49.


Google Scholar 

Shah C, Badiyan S, Berry S, Khan AJ, Goyal S, Schulte K, et al. Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy. Radiother Oncol. 2014;112:9–16.


Google Scholar 

Park HJ, Oh DH, Shin KH, Kim JH, Choi DH, Park W, et al. Patterns of practice in radiotherapy for breast cancer in Korea. J Breast Cancer. 2018;21:244–50.


Google Scholar 

Hong JC, Rahimy E, Gross CP, Shafman T, Hu X, Yu JB, et al. Radiation dose and cardiac risk in breast cancer treatment: an analysis of modern radiation therapy including community settings. Pract Radiat Oncol. 2018;8:e79–86.


Google Scholar 

Lohr F, El-Haddad M, Dobler B, Grau R, Wertz HJ, Kraus-Tiefenbacher U, et al. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys. 2009;74:73–80.


Google Scholar 

Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, et al. Modern radiation therapy and cardiac outcomes in breast cancer. Int J Radiat Oncol Biol Phys. 2016;94:700–8.


Google Scholar 

Ministry of Health and Welfare. Details on the criteria and methods for applying health insurance benefits, Act No. 2015-110. Sejong, South Korea: Health insurance review & assessment service; 2015; Jun 25. (in Korean)

Saiki H, Petersen IA, Scott CG, Bailey KR, Dunlay SM, Finley RR, et al. Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer. Circulation. 2017;135:1388–96.


Google Scholar 

Park JJ, Lee CJ, Park SJ, Choi JO, Choi S, Park SM, et al. Heart failure statistics in Korea, 2020: a report from the Korean Society of Heart Failure. Int J Heart Fail. 2021;3:224–36.


Google Scholar 

Berlin E, Ko K, Ma L, Messing I, Hollawell C, Smith AM, et al. Cardiac effects of modern breast radiation therapy in patients receiving systemic cancer therapy. JACC: CardioOncology. 2025;7:219–30.


Google Scholar 

Kimm H, Yun JE, Lee SH, Jang Y, Jee SH. Validity of the diagnosis of acute myocardial infarction in korean national medical health insurance claims data: the korean heart study (1). Korean Circ J. 2012;42:10–5.


Google Scholar 

Kim HY. Validity of the diagnosis of acute myocardial infarction in Korean national medical health insurance claims data [master’s thesis]. Seoul, South Korea: Yonsei University Graduate School of Public Health; 2013. (in Korean).


Google ScholarÂ